Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis

NCT03897075 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis
Moderate to Severe Nail Psoriasis

Interventions

DRUG: Tildrakizumab
DRUG: Placebo

Sponsor

Sun Pharmaceutical Industries Limited